Overview
Dr. Nina Wagner-Johnston is Professor of Oncology at the Johns Hopkins University School of Medicine. Her areas of clinical expertise include non-Hodgkin lymphoma, Hodgkin lymphoma, and HIV-related lymphomas. Dr. Wagner-Johnston serves as the Director for the Lymphoma Drug Development Program at the Johns Hopkins University. Dr. Wagner-Johnston received her baccalaureate degree in nursing from Georgetown University in Washington, DC. She earned her MD and completed her residency training at the University of Chicago, Chicago Illinois. She performed a fellowship in Medical Oncology at Johns Hopkins University, Baltimore, Maryland. Dr. Wagner-Johnston joined the Johns Hopkins faculty in 2015. Prior to joining Johns Hopkins, Dr. Wagner-Johnston was an Assistant Professor at Washington University, St. Louis, Missouri. Her research interests include clinical trial and biomarker development for patients with lymphoma. She is additionally involved in palliative/supportive care research and has a particular interest in chemotherapy-induced peripheral neuropathy. Dr. Wagner-Johnston serves as a member on the NCCN Cancer Related Fatigue Guidelines Panel and the ASCO Neuropathy Guidelines Panel. She has served as a journal reviewer for Annals of Oncology, Leukemia and Lymphoma, Blood, and the Journal of Nuclear Medicine. She is a previous recipient of a Young Investigator Award at the Supportive Oncology Conference as well as a Mentoring Program Award through the American Academy of Hospice and Palliative Medicine. She has served on the National Cancer Institute (NCI) Lymphoma Steering Committee Clinical Trials Design Committee and the NCI Symptom Management and Health Related Quality of Life Steering Committee. She is a member of the American Society of Hematology (ASH), the American Society of Clinical Oncology (ASCO), the AIDS Malignancies Consortium (AMC), and the Eastern Cancer Oncology Group (ECOG) Lymphoma Committee.
Dr. Wagner is highly rated in 22 conditions, according to our data. Her top areas of expertise are Non-Hodgkin Lymphoma, B-Cell Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.
Her clinical research consists of co-authoring 132 peer reviewed articles and participating in 14 clinical trials. MediFind looks at clinical research from the past 15 years.
Residency
Specialties
Licenses
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
Weinberg BLDG, Baltimore, MD 21287
5255 Loughboro Road Northwest, Building B, Washington, DC 20016
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
14 Clinical Trials
Office
Taofeek Owonikoko is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Owonikoko is highly rated in 18 conditions, according to our data. His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.
Johns Hopkins Bayview Medical Center
Patrick Forde is a Hematologist and an Oncologist in Baltimore, Maryland. Dr. Forde is highly rated in 12 conditions, according to our data. His top areas of expertise are Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Mesothelioma, and Small Cell Lung Cancer (SCLC).
Office
Blanche Alter is a Hematologist and an Oncologist in Rockville, Maryland. Dr. Alter is highly rated in 13 conditions, according to our data. Her top areas of expertise are Aase Syndrome, Dyskeratosis Congenita, Aplastic Anemia, Bone Marrow Transplant, and Hormone Replacement Therapy (HRT).
Frequently Asked Questions about Dr. Nina Wagner
How do I make an appointment with Dr. Nina Wagner?
You can book an appointment with Dr. Nina Wagner by calling their office at 410-955-8964. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Nina Wagner a top-rated expert for Non-Hodgkin Lymphoma?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Nina Wagner is classified as an Elite expert for Non-Hodgkin Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Nina Wagner specialize in?
While Dr. Nina Wagner is a Oncology, they have specific expertise in Non-Hodgkin Lymphoma, B-Cell Lymphoma, and Diffuse Large B-Cell Lymphoma (DLBCL). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Oncology.
Does Dr. Nina Wagner participate in research or clinical trials?
Yes. Dr. Nina Wagner has published 132 articles and abstracts on conditions like Non-Hodgkin Lymphoma. You can view a list of Dr. Nina Wagner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Nina Wagner accept my insurance?
Dr. Nina Wagner accepts most major insurance plans, including Aetna and CareFirst. We recommend calling the office directly at 410-955-8964 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- B-Cell LymphomaDr. Wagner isElite. Learn about B-Cell Lymphoma.
- Chronic Lymphocytic Leukemia (CLL)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Follicular LymphomaDr. Wagner isElite. Learn about Follicular Lymphoma.
- Mantle Cell Lymphoma (MCL)Dr. Wagner isElite. Learn about Mantle Cell Lymphoma (MCL).
- Non-Hodgkin LymphomaDr. Wagner isElite. Learn about Non-Hodgkin Lymphoma.
- Distinguished
- Chronic B-Cell Leukemia (CBCL)Dr. Wagner isDistinguished. Learn about Chronic B-Cell Leukemia (CBCL).
- Classical Hodgkin LymphomaDr. Wagner isDistinguished. Learn about Classical Hodgkin Lymphoma.
- Hodgkin LymphomaDr. Wagner isDistinguished. Learn about Hodgkin Lymphoma.
- Lymphofollicular HyperplasiaDr. Wagner isDistinguished. Learn about Lymphofollicular Hyperplasia.
- Advanced
- Bone Marrow TransplantDr. Wagner isAdvanced. Learn about Bone Marrow Transplant.
- Cutaneous T-Cell Lymphoma (CTCL)Dr. Wagner isAdvanced. Learn about Cutaneous T-Cell Lymphoma (CTCL).
- Gastric LymphomaDr. Wagner isAdvanced. Learn about Gastric Lymphoma.
- Graft Versus Host Disease (GvHD)Dr. Wagner isAdvanced. Learn about Graft Versus Host Disease (GvHD).
- Large-Cell Immunoblastic LymphomaDr. Wagner isAdvanced. Learn about Large-Cell Immunoblastic Lymphoma.
- LeukemiaDr. Wagner isAdvanced. Learn about Leukemia.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Wagner isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Acute Myeloblastic Leukemia with Maturation
- Acute Myeloblastic Leukemia without Maturation
- Acute Myeloid Leukemia (AML)Dr. Wagner isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Adult T-Cell LeukemiaDr. Wagner isExperienced. Learn about Adult T-Cell Leukemia.
- AgranulocytosisDr. Wagner isExperienced. Learn about Agranulocytosis.